
Rakesh Vasisht
About Rakesh Vasisht
Data last updated:
Rakesh Vasisht is a Director at Crozil Life Sciences (Opc) Private Limited (since 2018) and Director at Crozil Pharmaceuticals Private Limited (since 2018). The companies operate in Business Services and Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹39.5 Lakh; the largest is Crozil Life Sciences (Opc) Private Limited at ₹38.9 Lakh (FY 2019).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 16 Mar 2018 | 2017 | ₹38.9 Lakh (FY 2019) | Active | |
| Director | 07 May 2018 | 2018 | ₹55,000 (FY 2023) | Active |
Board colleagues of Rakesh Vasisht
| Name | DIN | Company | Designation |
|---|---|---|---|
| Vikas Kaushik | 07992744 | Crozil Life Sciences (Opc) Private Limited | Director |
| Shilpi Shiwangi | 08464302 | Crozil Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rakesh Vasisht
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rakesh Vasisht
Rakesh Vasisht currently holds 2 directorships: Crozil Life Sciences (Opc) Private Limited (Director, since 16 Mar 2018, revenue ₹38.9 Lakh (FY 2019)); Crozil Pharmaceuticals Private Limited (Director, since 07 May 2018, revenue ₹55,000 (FY 2023)).
Rakesh Vasisht was first appointed on 16 Mar 2018 as Director at Crozil Life Sciences (Opc) Private Limited.
The 2 current companies of Rakesh Vasisht that report revenue have a combined latest revenue of ₹39.5 Lakh: Crozil Life Sciences (Opc) Private Limited ₹38.9 Lakh (FY 2019); Crozil Pharmaceuticals Private Limited ₹55,000 (FY 2023).
The current boards of Rakesh Vasisht's companies include Vikas Kaushik (Crozil Life Sciences (Opc) Private Limited), Shilpi Shiwangi (Crozil Pharmaceuticals Private Limited).